{"organizations": [], "uuid": "a6fa5571ce389311f5df224764cf13a1ee1109c4", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 8}, "facebook": {"likes": 146, "shares": 146, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wsj.com", "main_image": "https://si.wsj.net/public/resources/images/BN-WX153_2lt3D_TOP_20180108192023.jpg", "site_section": "http://www.wsj.com/xml/rss/3_7014.xml", "section_title": "WSJ.com: US Business", "url": "https://www.wsj.com/articles/drug-industry-isnt-giving-up-on-alzheimers-1515457652", "country": "US", "domain_rank": 387, "title": "Drug Industry Isn’t Giving Up on Alzheimer’s", "performance_score": 1, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-09T02:27:00.000+02:00", "replies_count": 0, "uuid": "a6fa5571ce389311f5df224764cf13a1ee1109c4"}, "author": "Daniela Hernandez", "url": "https://www.wsj.com/articles/drug-industry-isnt-giving-up-on-alzheimers-1515457652", "ord_in_thread": 0, "title": "Drug Industry Isn’t Giving Up on Alzheimer’s", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Efforts to find treatments for Alzheimer’s disease suffered blows in recent days, but many companies, scientists and investors are still optimistic that they can find a way to treat the memory-robbing disease, which affects roughly 5.5 million Americans.\nAxovant Sciences Ltd. on Monday shuttered development for a once-promising Alzheimer’s drug, an announcement that came days after Pfizer Inc. said it was giving up on the space entirely. \n...  ", "external_links": [], "published": "2018-01-09T02:27:00.000+02:00", "crawled": "2018-01-09T09:40:51.787+02:00", "highlightTitle": ""}